Literature DB >> 825909

On the classification of antidepressant drugs.

P J Lewi, F C Colpaert.   

Abstract

Clinical, pharmacologic, and biochemical profiles of antidepressant drugs have been analyzed statistically. A method derived from multivariate statistics separates mere drug potency from the spectral information contained in the profiles. The dimensionality of the spectra is also reduced and this results in a diagram of associations and dissociations between the antidepressants and their scales of observation. The spectra of antidepressants show three poles which have been labeled as D (desipraminelike), A (amitriptylinelike), and M (MAOI). Clinical spectra agree better between one another than various pharmacologic spectra do. Monoamine oxidase inhibitors are readily differentiated from the tricyclic compounds. The latter appear in the sequence: desipramine, nortriptyline, imipramine, and amitriptyline. This sequence can also be reproduced from biochemical spectra of central and peripheral blockade of norepinephrine and serotonin reuptake.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 825909     DOI: 10.1007/BF00427294

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  8 in total

1.  Spectral mapping, a technique for classifying biological activity profiles of chemical compounds.

Authors:  P J Lewi
Journal:  Arzneimittelforschung       Date:  1976

2.  IS IT POSSIBLE TO PREDICT THE CLINICAL EFFECTS OF NEUROLEPTIC DRUGS (MAJOR TRANQUILLIZERS) FROM ANIMAL DATA?I. "NEUROLEPTIC ACTIVITY SPECTRA" FOR RATS.

Authors:  P A JANSSEN; C J NIEMEGEERS; K H SCHELLEKENS
Journal:  Arzneimittelforschung       Date:  1965-02

3.  A critical study on RO-4-1284 antagonism in mice.

Authors:  F C Colpaert; F M Lenaerts; C J Niemegeers; P A Janssen
Journal:  Arch Int Pharmacodyn Ther       Date:  1975-05

4.  The inhibition of human platelet 5-hydroxytryptamine uptake by tricyclic antidepressive drugs. The relation between structure and potency.

Authors:  A Todrick; A C Tait
Journal:  J Pharm Pharmacol       Date:  1969-11       Impact factor: 3.765

5.  An in vitro model for the study of psychotropic drugs and as a criterion of antidepressant activity.

Authors:  M H Kannengiesser; P Hunt; J P Raynaud
Journal:  Biochem Pharmacol       Date:  1973-01-01       Impact factor: 5.858

6.  A new design for the screening of CNS-active drugs in mice. A multi-dimensional observation procedure and the study of pharmacological interactions.

Authors:  C Morpurgo
Journal:  Arzneimittelforschung       Date:  1971-11

7.  [Therapy of depressions and depressive states].

Authors:  P KIELHOLZ; F LABHARDT; R BATTEGAY; W RUMMELE; H FEER
Journal:  Dtsch Med Wochenschr       Date:  1963-08-23       Impact factor: 0.628

8.  Uptake of 5-hydroxytryptamine by platelets.

Authors:  R S Stacey
Journal:  Br J Pharmacol Chemother       Date:  1961-06
  8 in total
  1 in total

1.  Course of depressive mood and psychomotor activation in endogenous depression.

Authors:  F Strian; W Albert; C Klicpera
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1979
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.